Alembic Pharma | APLLTD | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 2,056 | 808 | 1,058 | 611 | 755 |
Short-term investment |
| 0 | 0 | 1,870 | 83 | 68 |
Accounts receivables |
| 4,889 | 8,648 | 3,486 | 8,071 | 10,464 |
Inventories |
| 9,673 | 11,875 | 14,862 | 16,097 | 14,753 |
Deferred income taxes |
| 0 | 310 | 166 | 251 | 827 |
Other current assets |
| 2,960 | 2,987 | 4,338 | 3,494 | 2,234 |
Total current assets |
| 19,577 | 24,627 | 25,779 | 28,608 | 29,100 |
Gross property plant... |
| 10,984 | 15,249 | 17,037 | 17,415 | 23,985 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 10,984 | 15,249 | 17,037 | 17,415 | 23,985 |
Work in Progress |
| 13,414 | 15,741 | 19,443 | 22,058 | 6,013 |
Miscellaneous Investment |
| 488 | 176 | 493 | 1,184 | 963 |
Deferred income taxes |
| 0 | 0 | 0 | 59 | 1,230 |
Intangible assets |
| 2,663 | 2,990 | 3,229 | 1,548 | 0 |
Goodwill |
| 36 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 616 | 1,107 | 1,108 | 349 | 537 |
Total non-current assets |
| 28,200 | 35,263 | 41,311 | 42,612 | 32,728 |
Total assets |
| 47,778 | 59,890 | 67,090 | 71,220 | 61,828 |
Short-term debt |
| 4,291 | 8,605 | 0.2 | 6,300 | 6,359 |
Accounts Payable... |
| 7,023 | 6,259 | 6,688 | 7,064 | 6,798 |
Provisions |
| 324 | 382 | 520 | 636 | 701 |
Taxes Payable |
| 36 | 0 | 22 | 0 | 0 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 150 | 169 |
Other current liabilities |
| 3,222 | 2,270 | 5,579 | 3,015 | 2,343 |
Total current liabilities |
| 14,896 | 17,516 | 12,808 | 17,165 | 16,369 |
Long-term debt |
| 4,993 | 8,870 | 1,999 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 188 | 122 | 42 | 0 | 0 |
Provisions |
| 520 | 745 | 855 | 958 | 1,062 |
Capital Leases |
| 0 | 0 | 0 | 721 | 692 |
Other longterm liabilities |
| 0 | 733 | 715 | 0 | 0 |
Total non-current liabilities |
| 5,701 | 10,470 | 3,612 | 1,680 | 1,754 |
Total liabilities |
| 20,597 | 27,986 | 16,420 | 18,845 | 18,124 |
Share Capital |
| 377 | 377 | 393 | 393 | 393 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 26,811 | 31,817 | 50,883 | 51,982 | 43,312 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| -8 | -290 | -606 | 0 | 0 |
Total Equity |
| 27,180 | 31,905 | 50,670 | 52,375 | 43,705 |
Total Liabilities and Equity |
| 47,777 | 59,890 | 67,090 | 71,220 | 61,828 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |